|
Volumn 36, Issue 3, 2013, Pages 336-348
|
Pharmacokinetic study of berberine from rasont and implication of lysergol for its bioavailability enhancement
|
Author keywords
berberine; bioenhancer; column liquid chromatography; lysergol; pharmacokinetics; rasont
|
Indexed keywords
BERBERINE;
BIOENHANCER;
COLUMN LIQUID CHROMATOGRAPHY;
LYSERGOL;
RASONT;
LIQUID CHROMATOGRAPHY;
PHARMACOKINETICS;
BIOCHEMISTRY;
BERBERINE;
HERBACEOUS AGENT;
LYSERGOL;
RASONT;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG STABILITY;
DRUG STRUCTURE;
FREEZE DRYING;
LIMIT OF QUANTITATION;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
RAT;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ANIMALIA;
BERBERIDACEAE;
BERBERIS ARISTATA;
RATTUS;
|
EID: 84872350960
PISSN: 10826076
EISSN: 1520572X
Source Type: Journal
DOI: 10.1080/10826076.2012.657731 Document Type: Article |
Times cited : (6)
|
References (9)
|